Autori: Santoni Matteo
Naslov | Real-world effectiveness of pembrolizumab as first-line therapy for cisplatin-ineligible patients with advanced urothelial carcinoma: the ARON-2 study (Article; Early Access) |
Autori | Santoni Matteo ... Popovic Lazar S ... (broj koautora 43) |
Info | CANCER IMMUNOLOGY IMMUNOTHERAPY, (2023), vol. br. , str. - |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: |
|